Bifrost Biosystems Inc.

Berkeley, CA

UEI
D3CVBD71NMP7
CAGE
98CU8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1310 Ninth St, Berkeley, CA 94710, USA
Website
bifrost.bio
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $3,422,303
FY2025 $499,207
FY2024 $497,995
FY2023 $499,408

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Defense Advanced Research Projects Agency $3,422,303

Contract awards

Grant subawards

Prime recipient Prime award Amount Awarded
President And Fellows Of Harvard College Bifrost Biosystems will focus on developing the fundamental cassette/cartridge for microbial preservation, in terms of design, construction and scaled… HR00112420367 $2,751,397

Similar vendors

About the company

Bifrost Biosystems Inc., a Berkeley, California-based for-profit bioengineering manufacturer, serves the Defense Advanced Research Projects Agency as a small-business prime contractor and subcontractor, developing high-throughput cell screening and preservation technologies for defense bioengineering and pathogen detection applications.

Bifrost's federal footprint is concentrated entirely within DARPA, with three awards totaling $4.9 million in combined potential value across a three-year window (2023–2026). The vendor operates as prime on two DARPA awards: a $2.97 million Phase II SBIR definitive contract (total small business set-aside) awarded May 22, 2023, for robust operational ultra-high throughput cell lineage tracking, with completion targeted for November 30, 2027; and a $1.95 million Other Transaction Agreement awarded February 9, 2026, under the VAULT (Versatile Athermic Unit for Long-Duration Transport) program for high-throughput cell screening platforms, completing July 9, 2027. Bifrost also subcontracts to Harvard College (President and Fellows of Harvard College) as a sub-recipient on a federal grant awarded December 19, 2024, focusing on development of fundamental cassettes and cartridges for microbial preservation, including sample loading, long-term flow control without external pumps, thermostatic micro-coolers, and scaled production pathways.

The core capability across both prime and sub work centers on integrated platforms for high-throughput cellular interrogation and tracking — specifically, the ability to monitor up to one million separate cell lineages simultaneously while maintaining exceptional control over local conditions, performing in situ genotyping and time-lapse imaging of individual cells, and executing terminal assays on tracked lineages. The VAULT program builds on prior SBIR funding and collaborative development with Harvard, positioning the technology to support bioengineering and pathogen-detection applications critical to defense operations.

Recompete exposure is significant: both prime awards reach completion within the next twenty-four months, with combined potential value of $4.9 million at stake. Obligated dollars ($7.1 million) exceed the combined potential value, signaling either repricing, option exercises, or scope adjustments above the initial ceiling across the award portfolio.

Quick answers

Is Bifrost Biosystems Inc. registered in SAM.gov?

Yes. Bifrost Biosystems Inc.'s SAM.gov registration is active through March 3, 2027.

What is Bifrost Biosystems Inc.'s CAGE code?

Bifrost Biosystems Inc.'s CAGE code is 98CU8, and its Unique Entity ID (UEI) is D3CVBD71NMP7.

How much has Bifrost Biosystems Inc. received in federal contracts?

Federal contracts obligated $499,207 to Bifrost Biosystems Inc. in fiscal year 2025 and $4,918,913 in fiscal years 2023 through 2027.

What is Bifrost Biosystems Inc.'s most recent federal award?

Bifrost Biosystems Inc.'s most recent federal contract award is Vault (versatile athermic unit for long-duration transport) (HR0011269E094), from Defense Advanced Research Projects Agency, on February 9, 2026.

On GovTribe

See Bifrost Biosystems Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe